Avantor, Inc. — Director's Dealing 2022

Mar 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avantor, Inc. (AVTR)
CIK: 0001722482
Period of Report: 2022-03-01

Reporting Person: Brophy Gerard (EVP, Biopharma Production)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-01	Common Stock	S	2027	$34.47	Disposed	136221	Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.